​🚀 What does it take to go global and attract international investors? What can we learn from those who have done it?

​Melbourne's health and life science scene is on the rise - with more ventures, research and investment. Yet it can still be hard to break onto the global stage, attract international attention or know how to compete.

​So, we’re bringing together some of the experts who have cracked the code and are doing it!

​Join Tenmile, We VC, Proton Intelligence for an evening of insight, inspiration, and real talk - exploring the future of Medtech, scaling tech from Australia, and how international capital is flowing into local innovation.

​✨ Hosted by our partners ANDHealth at the Victorian Connected Health Innovation and Commercialisation Centre (CHICC)

​💚With support from What The Health & The Medtech Actuator

​🔍 Together, we’ll dive into:

• ​Global fundraising lessons & insights

• ​What corporate venture brings to the table (and how it differs from traditional VC)

• ​Opportunities for Aussie startups in the global stage

• ​Candid founder learnings from building and scaling

• ​What makes Melbourne an emerging magnet for global healthstartups

​🎤 Plus, live Q&A and plenty of time to network with fellow founders, investors, and innovators.

​📅 Details

• ​📅Wednesday, April 9th

• ​⏰ 5.30pm - 8pm

• ​📍CHICC, L2/99 Williams St Melbourne

• ​Drinks & nibbles provided 🍷🧀

• ​Who should come? Founders, investors, researchers, and anyone building or backing in Medtech, diagnostics or digital health.

​🧬 Meet the Speakers

​🎙️ Gemma Sturt – Senior Investment Manager, We Venture Capital (Werfen)

​Gemma brings 6+ years of experience building and investing in startups across life sciences. At We Venture Capital, the venture arm of global diagnostics leader Werfen, she focuses on frontier diagnostics and digital health.

She’s supported the deployment of several early-stage VC funds across Europe and the UK, including at BioCity (acquired in 2021). Prior to her investment career, she held commercial roles in VC-backed startups and studied Analytical Chemistry at the University of Manchester and Università degli Studi di Firenze.

Expect insights on how corporate venture approaches investment, what’s hot in diagnostics, and how Werfen views opportunities in Australia.

​Werfen is a global leader in specialized diagnostics, focused on areas like haemostasis, acute care diagnostics, autoimmunity, and OEM diagnostics. Headquartered in Barcelona, Werfen operates in over 30 countries and invests in cutting-edge technologies through its corporate venture arm, We Venture Capital.

​🎙️ Sahan Ranamukhaarachchi – Founder & CEO, Proton Intelligence

​A biomedical engineer turned serial entrepreneur, Sahan Ranamukhaarachchi has raised over $15M to build cutting-edge wearable medical devices. His work reimagines the skin as a powerful interface for drug delivery and biosensing — unlocking real-time data to transform clinical care. 

​As CEO of Proton Intelligence, he’s leading the development of the world’s first clinical-grade continuous potassium monitor — a game-changer for millions living with kidney and heart disease. Backed by investors across North America, Europe, Asia, and Australia, Proton is proudly building this breakthrough technology right here in Melbourne

​🎙️ Aizaz Syed – Portfolio & Investment Manager, Tenmile

​Aizaz leads, originates and manages investments for Tenmile as well as coordinating the overall portfolio strategy. He serves as a non-executive director of Aravax (Phase 2 peanut allergy immunotherapy) and Proton Intelligence.
With 10+ years of experience across early-stage investing, strategy and advisory roles, Aizaz previously worked at Nightingale Partners and Bank of America Merrill Lynch. He holds degrees in Law and Commerce from ANU and is admitted as a solicitor in NSW.

​🎙️Michelle Gallaher - Chief Executive Officer, Cerulea Clinical Trials

​Michelle is an award-winning thought-leader, speaker, advocate, and health technology entrepreneur. She has established four start-ups including Trialkey, which applies artificial intelligence to improving and predicting clinical trial results.

Commencing in allied health, Michelle’s career spans clinical and administrative roles in public and private health, commercial and executive roles with biotech, pharmaceutical, and medical organisations, as well as leading a biotech peak-body and influencing legislation and regulation in healthtech.

Michelle moved from the corporate world to found her first startup in 2014, successfully selling that business three years later and going on to found AI health tech company Opyl Ltd in 2019 (ASX: OPL).

Michelle is an experienced non-executive director on several boards (Praxis Australia, Cancer Trials Australia, and Medtech Actuator) and is co-founder of not-for-profit advocacy organisation, Women in STEMM Australia.

​🌟Brought to you by

​​🌏Tenmile is a health technology investment business that partners with early-stage companies to target unmet needs in healthcare and develop the Australian health commercialisation ecosystem. Launched in September 2022 with a $250m commitment we have team members in Perth, Sydney and Melbourne. Health technology covers digital health, diagnostics, medical devices, tools, and therapeutics.

​📱ANDHealth is Australia’s only organisation specialising in the commercialisation of evidence-based digital and connected health technologies. ANDHealth’s globally unique cooperative commercialisation model has led to significant growth within Australia’s nascent digital health sector and continues to be a driving force for the development of Australia’s capability in evidence-based, regulated, digital health technologies.

​CHICC
The Victorian Connected Health Innovation and Commercialisation Centre (CHICC) powered by ANDHealth, is Victoria’s digital health innovation hub, a vibrant community space for the digital & connected health sector, supported by the Victorian Government.

​🤖 MedTech Actuator has been designed to catalyse health-based startups transforming them into global companies that can deliver a new wave of healthcare and economic impact. Since 2018, we have rapidly become Asia-Pacific's premier MedTech commercialisation initiative delivering programs for healthcare startups in Australia, Singapore and Japan.

​
🍩 What the Health is Australia's leading media company and Community for all things health tech and innovation. With a weekly newsletter fast growing community of +9200 from all parts of the health, tech and innovation ecosystem, and a private community for experts & enthusiasts. Subscribe to their newsletter to keep on top of all things health tech and innovation!  💌